Connect with us


Univec, Inc. (OTCMKTS: UNVC) Reverses Northbound as Co Beefs Up BOD & Management Team (More on “Wraparound Services” Planned Expansion)

Univec, Inc. (OTCMKTS: UNVC) has been on the move northbound over the past few days since a brief dip below the $0.02-mark last week. UNVC has a very large…



Univec, Inc. (OTCMKTS: UNVC) has been on the move northbound over the past few days since a brief dip below the $0.02-mark last week. UNVC has a very large and very loyal shareholder base that continues to accumulate at current levels. The Company continues to make great progress since getting their filings in order and going “pink current” at the end of last year. A major feat for the Company as they had fallen way behind but are now compliant and in good shape on that front with the real possibility of becoming an SEC filer and going to OTCQB. UNVC does have a history of big moves rocketing up to $0.165 in February of last year. Investors are looking for a big week ahead as the Company continues on its growth and expansion plans 

UNVC has been busy in 2022, the corporate website has been advancing significant over the past few months. The Company’s OTCMarkets profile has been updated numerous times with the shell risk removed, another big step in the right direction. The Company plans to become a major player in “Wraparound Services” in the booming mental health and substance abuse environment. To that end Univec has been beefing up its BOD and management team recently adding T.I.M.E. Organization executive Lamont Ellis as new President and Lauren Herron as Vice President. They join CEO Dr. David Dalton, the first black pharmaceutical executive in the chain drug industry and a BOD that includes John C. Peoples, Past Vice President of Merck and Kenneth Grant past Vice President of Johns Hopkins Health System. 

Univec, Inc. (OTCMKTS: UNVC) is an organization targeted for change in the healthcare delivery system specializing in mental health and substance misuse. The Company plans to become a major player in “Wraparound Services” in the booming mental health and substance abuse environment  

UNVC is a Delaware corporation, incorporated on October 7, 1996, and the successor by merger to Univec, Inc., a New York corporation, incorporated on August 18, 1992. On March 1, 2014 the Company changed name to Univec Conglomerate, Inc. On June 19, 2021 the Company changed its name from Univec Conglomerate, Inc., to Univec, Inc., filed with the State of Delaware. 

The Company is led by Dr David Dalton; a visionary who was named as one of the “Top 100 Healthcare Leaders” for 2019 by the International Forum on Advancements in Healthcare.  With 45 years’ experience in the pharmaceutical world, Dr. Dalton served over 18 years as Vice President of Rite Aid, and then founded and served as Chairman, President, CEO of several successful pharmaceutical and pharmaceutical related companies including Mednet, ManagedcareRx, and Sivault Systems. Dr. Dalton is an inductee of three Halls of Fame, has received recognition from several presidents of the United States, and is a recipient of the Senatorial-Medal of Freedom. Dr. Dalton received a Doctor of Pharmacy from West Virginia University School of Pharmacy. In addition to his extensive background in pharmaceutical field, he is a visiting professor and lectures at several schools of pharmacy throughout the United States, and former President of West Virginia University School of Pharmacy Presidential Committee. Dr Dalton has built an impressive BOD for UNVC including John C. Peoples, Past Vice President of Merck as well as Kenneth Grant past Vice President of Johns Hopkins Health System.  

In August of last year, the Company announced the signing of a binding term sheet for the acquisition of accredited outpatient mental health centers in Maryland. These centers are community-based centers which provide outpatient mental health counseling treatment for substance abuse and other ancillary services. The acquisition will add in excess of $17million in topline revenue to Univec and is expected to close on or around September 30, 2021 subject to final due diligence and valuation. 

To Find out the inside Scoop on UNVC Subscribe to Right Now by entering your Email in the box below



This was when Univec’s business plan for “Wraparound Services” in the mental health and substance abuse environment was first revealed. These are enormous markets worth hundreds of billions where there is a lot of opportunity for a smart Company with good management. The US is in the midst of a mental health and substance abuse pandemic with over 100,000 people dying or overdose every year and new ideas are needed to address the problem. Univec intends to be at the forefront of delivering targeted care in the mental health arena by treating multiple aspects of the issues. 

In October Univec formed a partnership with bioRemedies MD, LLC, to offer safe adjunct therapies for pain, anxiety, and sleep disorders. bioRemedies MD’s proprietary cannabinoid-based products will be used by UNIVEC, Inc. in clinical behavioral health settings for out-patient treatment. bioRemedies MD specializes in cannabinoid-complementary and -integrative products. Their products have been in research and development at the company’s University of Maryland BioPark lab since industrial hemp research was legitimized 2016. 

bioRemedies MD’s scientifically formulated cannabinoid products are unlike anything on the market today. Through the use of FDA and pharmaceutical processes, technology, and standards, bioRemedies MD has been able to ensure high-quality, reproducible, and targeted formulations. Their proprietary nanotechnology delivers cannabinoids efficiently and effectively, a requirement for academic research and healthcare target markets, and allows their commercial products to compete on quality and cost. UNIVEC, Inc. will make private label and bioRemedies MD products available through several distribution channels throughout the U.S. market, including recently acquired community-based outpatient mental health centers. The partnership with bioRemedies MD is consistent with being in the forefront of delivering targeted care using custom-blend multi cannabinoid adjunct therapies.” 

UNIVEC, Inc. is working to change the way healthcare is delivered in the United States. The company works with several community-based outpatient mental health centers to treat behavioral health. bioRemedies MD complements UNIVEC, Inc. principles—treating the patient as a whole and applying “total wraparound” support for patients, families, and caregivers. 

UNVC has been busy beefing up its management team; they added Lamont Ellis as their new President. Ellis has more than 22 years growing and expanding T.I.M.E. Organization, Inc., a licensed Outpatient Mental Health Center (OMHC) providing community based mental health and behavioral health services including counseling, PRP, substance abuse, services and other wraparound services.  The tireless efforts and visionary leadership of Ellis has grown T.I.M.E. to a$20,000,000 revenue organization. 

UNVC also appointed Lauren Herron as Vice President. Ms. Herron earned a Bachelor’s degree in social work and Sociology and Masters in Social work graduating Cum Laude from the University of Maryland. She said “I look forward to joining Univec, Inc. as Vice President addressing the mental health and medical needs of our communities by promoting an affordable, holistic approach as the model of treatment.” 

For More on UNVC Subscribe Right Now!

Currently trading at a $56 million market valuation UNVC is on the rise since a major reversal that started last week after a brief dip below the $0.02 mark. The Company is gearing up for something big, beefing up its BOD and management team as it embarks on its plan to become a major player in “Wraparound Services” in the booming mental health and substance abuse environment. Investors are looking for a big week ahead as the Company continues on its growth and expansion plans. Like any penny stocks UNVC has its risks, although the risk reward ratio was raised significantly when the Company became “pink current” got the shell risk removed and filed their annual report 2 weeks early with OTCmarkets. UNVC speculators are looking for a break back to previous highs and beyond as the Company continues to executive in 2022. Microcapdaily first reported on UNVC on October 28, 2018 when the stock was around $0.005 long before it ran to $0.165 up 3,000% from our first article. We will be updating on UNVC when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with UNVC.

Sign Up now for our 100% FREE Penny Stock Newsletter

Disclosure: we hold no position in UNVC either long or short and we have not been compensated for this article.

The post Univec, Inc. (OTCMKTS: UNVC) Reverses Northbound as Co Beefs Up BOD & Management Team (More on “Wraparound Services” Planned Expansion) first appeared on Micro Cap Daily.

Read More

Continue Reading

Spread & Containment

FTSE 100 gains as commodity-linked stocks bounce back

The commodity-heavy FTSE 100 gained 0.4%, while mid-cap FTSE 250 index inched up 0.3% UK’s FTSE 100 gained on Monday, as an easing of COVID-19 restrictions…



The commodity-heavy FTSE 100 gained 0.4%, while mid-cap FTSE 250 index inched up 0.3%

UK’s FTSE 100 gained on Monday, as an easing of COVID-19 restrictions in China brought relief to commodity prices, lifting shares of major oil and mining companies.

As of 0704 GMT, the commodity-heavy FTSE 100 gained 0.4%, while mid-cap FTSE 250 index inched up 0.3%.

The risk sentiment improved after a Wall Street rally late last week and a rebound in copper and iron ore prices on Monday, boosted by an easing COVID-19 restrictions in Shanghai and relaxed testing mandates in several Chinese cities.

The burst of global enthusiasm for equities has put a spring in the step of the FTSE 100 at the start of the week, Hargreaves Lansdown analyst Susannah Streeter said.

Mining stocks led gains on the FTSE 100 index, with Anglo American, Rio Tinto and Glencore rising more than 3%, after Group of Seven leaders pledged to raise $600 billion private and public funds in five years to finance needed infrastructure in developing countries.

It is hoped this scheme, seen as a counter to China’s Belt and Road Initiative, will set off a spurt of spending and demand for commodities around the world, Streeter added.

Among individual stocks, CareTech surged 20.8% after the UK-based provider of care and residential services agreed to be acquired by a consortium led by Sheikh Hoidings in an 870.3 million pounds ($1.07 billion) deal.

Carnival Corp jumped 5.6%, extending its Friday gains after the leisure travel company forecast a positive core profit for the current quarter despite surging costs.

London-listed shares of Rio Tinto added 2% after a U.S appeals court ruled that the federal government may give the UK copper miner a right to lands in Arizona.

BAE Systems inched up 0.4% after the defence company received a $12 billion contract from the U.S Department of Defence.

The post FTSE 100 gains as commodity-linked stocks bounce back first appeared on Trading and Investment News.

Read More

Continue Reading


The Depopulation Of Taiwan

The Depopulation Of Taiwan

Authored by Igor Chudov via Igor’s Newsletter,

This is a continuation of my post from yesterday about a massive…



The Depopulation Of Taiwan

Authored by Igor Chudov via Igor's Newsletter,

This is a continuation of my post from yesterday about a massive 13% decline in births in Germany. Such a decline is a nine-sigma event, meaning that it is so unlikely to occur by chance, that it would naturally happen as rarely as an asteroid striking the Earth.

My article explored several more locales (UK, North Dakota, and Switzerland).

But no other place stands out as much as Taiwan does.

23% Drop in Birth Rate in Taiwan

According to a Taiwan government report, the birth rate dropped by 23.24% in May 2022, compared to May 2021.

I inputted historical birth rate data from Macrotrends for the years 2009-2021, and added the year 2022 as year 2021 adjusted down by 23.24%. Obviously, 2022 is not over and the number of Taiwanese babies to be born this year (or during the next 12 months) is unknown. So the chart below is an illustration of what would happen in the next 12 months if the 23.24% drop stays constant.

When expressed in “sigmas”, units of standard deviation, the 23.24% drop in the birth rate in Taiwan is a 26-sigma event!

This is can be described as “unimaginable” in terms of the likelihood of happening due to random chance.

The Wolfram-Alpha illustration of likelihood by sigma only goes to ten-sigma. They thought that it would be pointless to show more sigmas. Except a 26-sigma drop in birth rate just happened in Taiwan.

What Happened In Taiwan?

Health experts are quick to blame Covid for all sorts of health problems afflicting those they advised to vaccinate. It is not the vaccine, they say, it is Covid. We tried to protect you with the vaccine, they would always insist. But you got Covid anyway, thanks to the evil antivaxxers, and your problems are due to Covid — that’s their explanation.

We know for certain, though, that the drop in birth rate in Taiwan is NOT due to Covid. Yes, Taiwan is suffering from a terrible COVID pandemic right now (despite being 91% vaccinated), however, Covid in Taiwan only started around April 21 of 2022, and could not impact May birth rates much.

To see what could cause the extreme drop in births, go back 9 months from May 2022, so to September 2021.

Taiwan was a poster child for successful vaccination. 91% of all Taiwanese residents received a vaccine dose. By October 1, 2021, 56% of ALL people of Taiwan received Covid vaccines.

They got a fairly usual mix of “safe and effective” AstraZeneca, Moderna, and Pfizer vaccines.

People of Taiwan got their shots, felt assured that Covid-19 stops with every vaccinated person, and moved on with their lives.

I doubt that the people of Taiwan noticed anything at the end of September. They knew for sure that their vaccines were safe and effective and would not affect their sperm or pregnancies. So they proceeded with family plans just as before, trying to make babies on purpose, or partying and having fun and getting pregnant accidentally, just as people do elsewhere.

Except for 9 months later, they only gave birth to 77% of the number of babies expected.

I hope that the people of Taiwan will start asking their authorities: what is happening to us?

A Glimmer of Hope

If you are like me, and you like babies, children, and grandchildren, you are probably upset by now and are wondering what will happen to all of us. Let me mention a possibility that, although unlikely in my opinion, may make this drop in birth rates temporary.

Covid vaccines are known to “disrupt the menstrual cycle” and lower sperm counts. It is possible that some women, for a period of several months, could not conceive and become pregnant due to these disruptions. Because all Taiwanese women were vaccinated at almost the same time, those disruptions created a precipitous drop in birth rates.

My hope, as someone who likes people, is that this will turn out to be the case. However, in my opinion, we will likely see the opposite, and reductions in birth rates will be permanent. Why? Because vaccinating young people was a crime. It was not a mistake. Let me not explain why, in this article.

Crimes like this are NOT perpetrated to achieve a two-month drop in birth rates. Criminals of such nature who gave young people shots that they did not need, for sinister reasons, go for the jugular. Of course, not all people participating in vaccination campaigns were having such sinister intentions. But it is possible that some persons on top had criminal motives that they did not disclose.

Again, I hope that the preceding paragraph will turn out to be unfounded. I was, and am, against any of that happening, do not support anything that is happening in Taiwan, and I am very worried.

Time will tell.

They Told Us it is Safe

This fact check from Dec 5, 2020 says that the vaccine is definitely safe for pregnancy “because there is no evidence that it is unsafe”. No trial specifically for pregnancy and fertility was conducted. They just lied to us that it is safe — but had no way of knowing.

Subscribe here...

Tyler Durden Mon, 06/27/2022 - 23:15

Read More

Continue Reading


Hot Penny Stocks to Buy This Week? 3 For Your List 

Can these penny stocks continue to climb
The post Hot Penny Stocks to Buy This Week? 3 For Your List  appeared first on Penny Stocks to Buy, Picks, News…



3 Hot Penny Stocks to Add to Your Watchlist This Week 

Let’s face it, finding penny stocks to buy is not easy. And over the past few months, it has been increasingly challenging to make money with small caps. Now, while this may be true, not every investor has lost money in that time. Rather, to make money with penny stocks, traders have to be extra careful and know what penny stocks to buy. 

[Read More] Best Penny Stocks to Buy as June Ends? 3 to Watch 

There are a few key things to look for when finding penny stocks to buy. The first is a reason that it may move. When penny stocks shift up or down, there are numerous causes. But, most penny stocks will have a fundamental reason to do so. This could be a new product launch, an FDA approval, or anything else that would increase demand for the company’s shares. 

The second is liquidity. This is key because you need to be able to buy and sell penny stocks quickly. If there is not enough liquidity or shares traded in a day, you may be stuck with your penny stock. 

The last is price. You obviously want to buy penny stocks that are cheap, but you also want to make sure that the company is valued appropriately. This means looking at its fundamentals and understanding why it is at its given value. With all of this in mind, let’s take a look at three penny stocks to add to your watchlist this week.

3 Penny Stocks to Watch This Week 

  1. Visionary Education Technology Holding Group Inc. (NASDAQ: VEDU)
  2. RLX Technology Inc. (NYSE: RLX)
  3. Uranium Energy Corp. (NYSE: UEC

Visionary Education Technology Holding Group Inc. (NASDAQ: VEDU) 

One of the largest gainers of the day on June 27th was VEDU stock. By EOD, shares of VEDU had shot up by more than 30% with an over 5% after-hours gain. And, in the past five days, shares of VEDU stock have exploded by over 120%. These major gains come alongside no recent news. The most recent news however, came on May 19th. 

[Read More] Penny Stocks: Looking At The Big Picture For Tiny Stocks

On the 19th, the company announced the closing of its $17 million firm commitment IPO. This came with 4.25 million shares at a public offering price of $4 per share. For some context, Visionary Education is a Canadian based company offering high-quality education resources to students around the world. While it has fallen from its IPO price to around $2.60, its recent bullish momentum is exciting without a doubt. So, with all of this in mind, will VEDU be on your penny stocks watchlist or not?

RLX Technology Inc. (NYSE: RLX) 

With over 3% in gains during trading and after hours on June 27th, RLX is another penny stock that investors are watching right now. In the past month, we’ve seen shares of RLX climb by more than 19%, which is no small feat. The most recent news from the company came in the form of its unaudited Q1 2022 financial results. In the results, the company saw its net revenue decline slightly, however, it stated that this was due to the pandemic. 

“During the first quarter of 2022, we continued to focus on our core strategy and maintain our leading position in the industry while preparing for the anticipated regulatory changes.

As the new regulatory framework has come into effect and detailed implementation measures have been released, we are proactively adapting our business to the new market environment by applying for the relevant licenses and developing qualified products that meet the requirements of the most recent national standards.”

The CEO of RLX Technology, Ms. Ying Wang

While this news was not ideal, it did bring shares of RLX stock down to lower levels. And as a result, its recent bullish momentum could be due to RLX being at value prices. Whether this makes RLX worth adding to your list of penny stocks to buy, is up to you. 


Uranium Energy Corp. (NYSE: UEC) 

On June 27th, UEC stock saw modest gains however, it did post abnormally high volume. And because of this, many investors are keeping a close eye on it right now. The most recent update from the company came on June 22nd, when it announced its entrance into a definitive agreement with UEX Corporation. It stated that it would acquire all of the outstanding shares of UEX with a C$5 million private placement. 

This is big news for the company and should add to its large and growing business. If you’re not familiar, Uranium Energy is a uranium mining company. And, recently, we’ve seen heightened interest in alternative energy penny stocks. And although UEC is highly volatile, it is an interesting penny stock to watch. With this considered, does UEC deserve an addition to your watchlist or not?


Which Penny Stocks Are You Buying Right Now?

After a relatively flat day of trading, investors are looking for the best penny stocks to buy this week. That involves understanding what factors are impacting the stock market, and how we can use those to benefit.

[Read More] Penny Stocks To Watch: Why EVFM, AGRX, CYBN, HILS & AFIB Stock Are Moving

Although trading is not easy, there are plenty of ways to find penny stocks to buy in 2022. So, with this in mind, which penny stocks are you buying right now?

[reblex id='29520']

The post Hot Penny Stocks to Buy This Week? 3 For Your List  appeared first on Penny Stocks to Buy, Picks, News and Information |

Read More

Continue Reading